IPS TMS for Patients with PTSD

Brief description of study

This study will be the first of its kind to explore the impact of continuous theta burst stimulation (cTBS) to the intraparietal sulcus (IPS) on arousal symptoms among patients with posttraumatic stress disorder (PTSD). We will demonstrate that IPS cTBS results in significant target engagement in the form of reduction in anxiety-potentiated startle (APS) compared to sham cTBS and will identify the ideal dose of cTBS.

Eligibility of study

You may be eligible for this study if you meet the following criteria:

Conditions:
PTSD
Age: Between 18 Years - 60 Years
Gender: All

Male or Female, Age 18-60, Diagnosed with PTSD, right-handed, no metal implants, not pregnant, no history of seizures/seizure disorders, ability to read and write in English

Updated on 26 Apr 2024. Study ID: 849571

You have contacted , on

Your message has been sent to the study team at ,

A copy of the message has been sent to your email

What happens next?

You can expect the study team to contact you via email or phone in the next few days.
Sign up as volunteer to help accelerate the development of new treatments and to get notified about similar trials.

You are contacting

By sending a message, I agree that my data will be sent to a representative for the selected site and processed in accordance with this website's Privacy Policy (see link in footer).